跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE HYDROCHLORIDE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE HYDROCHLORIDE INJECTION
Authorized
STANDARD
LIDOCAINE HYDROCHLORIDE INJECTION
Laboratoire Aguettant
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dc3e525c3971e566
Company
Laboratoire Aguettant
Type
Standard
Approval Details
Approval Id
dc3e525c3971e566
Drug Approval Canada Name
LIDOCAINE HYDROCHLORIDE INJECTION
Product Name
LIDOCAINE HYDROCHLORIDE INJECTION
Status
Marketed
Status Date
2023-04-19
Original Market Date
2023-04-19
Din
02522268
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
24:04.04.08
Atc Original
C01BB01 LIDOCAINE
Atc Name
c 01 bb 01
Aig Number
0101280001
Company Name
Laboratoire Aguettant
Company Address
1, Rue Alexander Fleming, Lyon, Rhône, France, 69007
Company Detail Path
/organization/laboratoire-aguettant
Company Information
Pharmaceutical Company Name
Laboratoire Aguettant
Country Name
Belgium
City Name
unknown,country_be
Address
Unknown Belgian address
Website
https://www.aguettant.co.uk
Active Ingredients
LIDOCAINE HYDROCHLORIDE
100 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dc3e525c3971e566
Type
Standard
Back to Health Canada Approvals